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Sarcoidosis Presenting with Massive Pleural Effusion and Elevated 
Serum and Pleural Fluid Carbohydrate Antigen-125 Levels
In Seon Lee, M.D., Sae Byul Kim, M.D., Chan Soo Moon, M.D., Sung Mo Jung, M.D., Song Yee Kim, M.D., 
Eun Young Kim, M.D., Ji Ye Jung, M.D., Young Ae Kang, M.D., Ph.D., Young Sam Kim, M.D., Ph.D., Se 
Kyu Kim, M.D., Ph.D., Joon Chang, M.D., Ph.D., Moo Suk Park, M.D., Ph.D.
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, The Institute of Chest Diseases, Yonsei 
University College of Medicine, Seoul, Korea
A 55-year-old woman was admitted for an elevated serum carbohydrate antigen-125 (CA-125) level, and a left 
pleural effusion, which were detected at a routine health examination. Computed tomography of the chest was 
performed upon admission, revealing extensive bilateral paratracheal and mediastinal lymph node enlargement 
with a massive left-sided pleural effusion. Subsequent analysis of the pleural fluid demonstrated consistency with 
an exudate, no evidence of malignant cells, and a normal adenosine deaminase. However, the pleural fluid and 
serum CA-125 levels were 2,846.8 U/mL and 229.5 U/mL, respectively. A positron emission tomography did not 
reveal any primary focus of malignancy. Finally, a surgical mediastinoscopic biopsy of several mediastinal lymph 
nodes was performed, revealing non-necrotizing granulomas, consistent with sarcoidosis. After a month of treatment 
of prednisolone, the left pleural effusion had resolved, and after 2 months the serum CA-125 level was normalized.
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Introduction
Massive pleural effusions can be produced by many 
causes, including sarcoidosis. However, pleural involve-
ment of sarcoidosis is rare, with an incidence in the lit-
erature of approximately 1∼10%1. Carbohydrate (or 
cancer) antigen-125 (CA-125) is a glycoprotein that has 
been associated with ovarian carcinoma and several 
other non-gynecologic malignancies2. Herein, we report 
a case of a massive pleural effusion due to pleural sar-
coidosis, with associated increases in pleural and serum 
CA-125 levels that normalized after steroid therapy. 
Case Report
　A 55-year-old woman was admitted for further evalu-
ation of an elevated serum CA-125 and a left pleural 
effusion identified by her primary care physician at a 
routine health examination. At the time, the patient 
complained of a mild dry cough and dyspnea on ex-
ertion which had been present for several months. She 
also endorsed an unintentional weight loss of 3 kg dur-
ing the preceding 2 months. 
　The patient had a history of a hysterectomy with bi-
lateral salpingo-oophorectomy for treatment of uterine 
myomatosis 5 years previously. She has been taking 
medicine for hypertension, and denied any history of 
tuberculosis. She had no specific contributory family 
history. She had no history of tobacco or alcohol use. 
She was a housewife.
Case Report
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Figure 1. (A) The initial 
chest X-ray showed a left- 
sided massive pleural effu-
sion, which disappeared af-
ter 2 months of medication 
with oral prednisolone (B).
1. Physical examinations
The blood pressure was 128/83 mm Hg, the pulse 
rate was 80 beats per minute, the body temperature was 
36.1oC, the respiratory rate was 18 breaths per minute, 
and the oxygen saturation was 100% while breathing 
ambient air. There was no palpable lymph node en-
largement in the head, neck, or axillae. The lung 
sounds were noted to be dull to percussion at the left 
hemithorax, and diminished at the left base. The re-
mainder of the physical examination was normal. 
2. Laboratory findings
The serum CA-125 was significantly elevated (229.5 
U/mL), as was the serum angiotensin-converting en-
zyme (119 U/L). All other tumor markers were within 
normal limits. Other test results were also normal, in-
cluding white blood cell and platelet counts, measure-
ments of electrolytes, glucose, protein, albumin, glob-
ulin, and bilirubin, tests of hepatic and renal function, 
and urinalysis. An acid-fast bacillus (AFB) smear of the 
patient's sputum was negative, with no organisms ob-
served on sputum culture.
Thoracentesis and pleural biopsy were then per-
formed, yielding 500 mL of clear yellow pleural fluid. 
The pleural fluid analysis revealed an exudative pattern, 
with a protein level of 5.6 g/dL (the serum protein level, 
7.3 g/dL), a lactate dehydrogenase level of 269 IU/L (the 
serum lactate dehydrogenase level, 322 IU/L), a glucose 
of 39 mg/dL, an albumin of 3.4 g/dL and pH of 7.2. 
Additionally, a cell count of the pleural fluid was per-
formed showing 4,850 cells/μL (polymorphonuclear 
cells 0%, lymphocytes 100%, eosinophils 0%, basophils 
0%, and other cells 0%), with a pleural fluid CA-125 
concentration of 2,846.8 U/mL and an adenosine deami-
nase concentration of 37.8 IU/L. No malignant cells 
were observed on cytology. All bacterial, fungal and 
mycobacterial cultures of the pleural fluid were 
negative. The results of pulmonary function tests were 
within normal limit, and an electrocardiogram was 
normal.
3. Image findings
　A chest radiograph showed findings consistent with 
a massive left-sided pleural effusion and bilateral hilar 
prominence (Figure 1A). A contrast-enhanced com-
puted tomography (CT) of the chest demonstrated ex-
tensive bilateral paratracheal and mediastinal lympha-
denopathy, and left-sided pleural effusion (Figure 2A), 
without any lesions involving the lung parenchyma. A 
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Figure 2. (A) The initial 
chest computed tomogra-
phy showed a left-sided 
pleural effusion and media-
stinal lymph nodes enlar-
gement. (B) The 18F-fluoro-
deoxyglucose-positron- 
emission tomography re-
vealed intense uptake on 
the bilateral paratracheal, 
hilar, and supraclavicular 
lymph nodes.
subsequent 18F-fluorodeoxyglucose-positron-emission to-
mography (18F-FDG-PET) revealed FDG activity in the 
bilateral paratracheal, hilar, and supraclavicular lymph 
nodes, which were suspicious for malignancy. However, 
there was no evidence of any other specific focus of 
malignancy (Figure 2B). Similarly, the patient's breast 
ultrasonography, mammography, and Pap smear at the 
most recent health care examination did not indicate 
any malignant focus, nor did the esophageal gastro-
duodenoscopy or colonoscopy. A contrast-enhanced CT 
of the abdomen likewise revealed no significant abnor-
mal findings.
4. Bronchoscopic findings
On bronchoscopic examination, there was mild blunt-
ing at the main carina, and there were multiple elevated 
nodules in the proximal medial walls of the left second 
carina and the left lower lobar bronchus. There was no 
evidence of respiratory viruses, fungi, or bacteria. And 
the result of AFB smear in the bronchial washing speci-
men was negative.
5. Histopathological findings
Pleural fluid cytology was negative for malignant cells, 
whereas the pleural biopsy showed chronic gran-
ulomatous inflammation with giant cells. Ziehl-Neelsen 
and diastase-pretreated periodic acid-Schiff stains re-
vealed no infectious organisms. Pathologic findings from 
multiple nodules of the fiberoptic bronchoscopic biopsy 
revealed non-necrotizing granulomas in the bronchial 
wall, suggesting no definitive findings (Figure 3A), and 
transbronchial needle aspiration cytology was negative 
for malignancy. Finally, a surgical mediastinoscopic bi-
opsy of the right paratracheal lymph nodes was per-
formed, showing non-necrotizing granulomas consistent 
with sarcoidosis (Figure 3B). Taken together, pleural 
sarcoidosis with lymph node and endobronchial in-
volvement was diagnosed.
6. Treatment and progress
The patient was started on a treatment regimen of 1 
mg/kg oral prednisolone. After one month, the left 
pleural effusion was resolved (Figure 1B), and the se-
rum angiotensin converting enzyme level was decreased 
from 119 U/L to 18 U/L. After 2 months of oral pre-
dnisolone therapy, the serum CA-125 level was normal-
ized (229 U/mL to 34 U/mL). No signs of relapse were 
observed during a 5-month steroid tapering period, and 
the pleural effusion never recurred during the sub-
sequent 5-year follow-up period after discontinuing the 
steroids. 
Discussion
Sarcoidosis is a multisystem disease of unknown ori-
gin, resulting in classic granulomatous-type inflamma-
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Figure 3. (A) The fiberoptic bronchoscopic biopsy revealed non-necrotizing granulomas in the bronchial wall (H&E stain,
×100). (B) The mediastinoscopic biopsy of right paratracheal lymph node revealed that all normal structures were entirely
replaced by non-caseating granulomas, each composed of aggregates of tightly clustered epithelioid cells (H&E stain,
×400).
tion3. Sarcoidosis involving the pleura is rare, and usu-
ally manifests itself as non-specific pleural thickening, 
pleural effusion, and pneumothorax. Huggins et al.1 re-
ported that only 2 of 181 sarcoidosis patients (1.1%) 
was observed a pleural effusion secondary to sarcoi-
dosis via chest ultrasonography. Moreover, patients with 
pleural sarcoidosis usually have pulmonary involve-
ment.
Pleural effusion secondary to sarcoidosis can present 
unilaterally or bilaterally, with the right side (45%) more 
often affected than the left (33%)4 for unclear reasons. 
In most cases, the actual amount of pleural effusion is 
small to moderate, though some cases of massive pleu-
ral effusion have been reported. Furthermore, the pleu-
ral effusion type associated with sarcoidosis has gen-
erally been a lymphocyte-predominant exudate, though 
a transudate with a predominance of eosinophils has 
occurred in a minority of cases5.
The diagnosis of sarcoidosis is supported by clinical 
and radiologic findings, in addition to histopathology 
consistent with noncaseating granuloma in one or more 
organs. Notably, no pathognomonic histologic features 
exist for granulomas associated with sarcoidosis. More-
over, a pleural biopsy sample demonstrating non-
caseating granulomas is required to diagnose pleural 
sarcoidosis, and all other causes of pleural effusion must 
be ruled out, such as tuberculosis, malignancy, or con-
gestive heart failure6. Specifically, tuberculous gran-
ulomas show caseation, which can help distinguish tu-
berculoma from sarcoidosis, though this feature may not 
be present in all the cases. As such, all biopsy speci-
mens should be thoroughly evaluated for underlying in-
fectious agents, particularly Mycobacterium tuberculosis.
CA-125 is a high molecular glycoprotein originating 
from embryonic coelomic epithelia, of which the fallo-
pian tubes, endometrium, endocervix, pleura, pericar-
dium, and peritoneum are derived2. Serum CA-125 lev-
els are often used as a tumor marker in ovarian carcino-
ma, as it is often initially elevated and decreases after 
chemotherapy or tumor resection. However, serum 
CA-125 levels may also be elevated in the setting of 
non-gynecological malignancies (including lung cancer 
and non-Hodgkin's lymphoma), and various other be-
nign conditions (such as liver disease, ascites, con-
nective tissue disease, and chronic constrictive peri-
carditis). Furthermore, some evidence suggests that 
granulomatous conditions can also cause elevations in 
serum CA-125. For instance, tuberculosis can result in 
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massive pleural effusions with secondary elevation of 
CA-1257. Additionally, CA-125 elevation has been asso-
ciated with cases of peritoneal, pleural, and pulmonary 
sarcoidosis2.
In our patient, underlying liver, renal, or rheumato-
logic disease were not ever identified, and there were 
not any evidence to suggest past or present tuberculous 
infection. To exclude malignancy and other associated 
benign conditions, an extensive workup was performed, 
including 18F-FDG-PET, contrast-enhanced CT of the ab-
domen, esophageal gastroduodenoscopy, colonoscopy, 
mammography, and breast ultrasonography, which 
identified no other cause that could underlie the ele-
vated serum CA-125. In this way, sarcoidosis was felt 
to be the only etiologic factor resulting in the elevated 
serum CA-125 and large pleural effusion, without pul-
monary nor peritoneal involvement2.
The treatment of sarcoidosis with pleural involvement 
should be determined on a case-by-case basis, as these 
effusions usually resolve spontaneously within 1∼3 
months4,6. Systemic corticosteroids should only be con-
sidered in patients with symptomatic disease and for 
cases of recurrent pleural effusion, as persistent pleural 
effusions may lead to chronic pleural irritation, pleural 
thickening, and ultimately fibrothorax. Our patient suf-
fered from progressive dyspnea on exertion with an in-
creasingly massive pleural effusion, and was thus suc-
cessfully treated with systemic corticosteroids.
In conclusion, sarcoidosis can be the cause of mas-
sive pleural effusion as well as elevated serum CA-125 
levels. Clinicians should consider sarcoidosis as a differ-
ential diagnosis in patients with massive pleural effusion 
or elevated serum CA-125, even without pulmonary or 
peritoneal involvement.
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